| Literature DB >> 27792645 |
Jennifer A Sumner1, Yulia Khodneva2, Paul Muntner3, Nicole Redmond2, Marquita W Lewis2, Karina W Davidson4, Donald Edmondson4, Joshua Richman5, Monika M Safford6.
Abstract
BACKGROUND: Psychosocial risk for cardiovascular disease (CVD) may be especially deleterious in persons with low socioeconomic status. Most work has focused on psychosocial factors individually, but emerging research suggests that the confluence of psychosocial risk may be particularly harmful. Using data from the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study, we examined associations among depressive symptoms and stress, alone and in combination, and incident CVD and all-cause mortality as a function of socioeconomic status. METHODS ANDEntities:
Keywords: cardiovascular diseases; depression; mortality; socioeconomic status; stress
Mesh:
Year: 2016 PMID: 27792645 PMCID: PMC5121497 DOI: 10.1161/JAHA.116.003930
Source DB: PubMed Journal: J Am Heart Assoc ISSN: 2047-9980 Impact factor: 5.501
Baseline Characteristics of REGARDS Participants Free of CVD With Neither, Either, or Concurrent Elevated Depressive Symptoms and Perceived Stress Shown Separately for High and Low Income
| Characteristic | Income ≥$35 000 | Income <$35 000 | ||||||
|---|---|---|---|---|---|---|---|---|
| No Depressive Symptoms and No/Low Stress (n=8256) | Elevated Depressive Symptoms or Stress (n=2234) | Elevated Depressive Symptoms and Stress (n=380) |
| No Depressive Symptoms and No/Low Stress (n=5536) | Elevated Depressive Symptoms or Stress (n=2500) | Elevated Depressive Symptoms and Stress (n=984) |
| |
| Sociodemographics | ||||||||
| Age, y, mean (SD) | 62.1±8.5 | 60.6±8.9 | 58.0±8.2 | <0.001 | 66.9±9.0 | 65.4±9.7 | 62.2±9.6 | <0.001 |
| Female, n (%) | 3740 (45.3) | 1338 (59.9) | 260 (68.4) | <0.001 | 3535 (63.9) | 1777 (71.1) | 750 (76.2) | <0.001 |
| Black, n (%) | 2529 (30.6) | 800 (35.8) | 134 (35.3) | <0.001 | 2786 (50.3) | 1445 (57.8) | 600 (61.0) | <0.001 |
| Did not graduate from high school, n (%) | 187 (2.3) | 64 (2.9) | 17 (4.5) | 0.01 | 921 (16.6) | 544 (21.8) | 280 (28.5) | <0.001 |
| Number of people in the household, median (IQR) | 2 (2–3) | 2 (2–3) | 2 (2–3) | <0.001 | 2 (1–2) | 2 (1–2) | 2 (1–3) | <0.001 |
| Lives alone, n (%) | 1296 (15.7) | 372 (16.7) | 83 (21.8) | 0.005 | 2270 (41.0) | 990 (39.6) | 371 (37.7) | 0.11 |
| Region | 0.09 | <0.001 | ||||||
| Stroke belt, n (%) | 2599 (31.5) | 750 (33.6) | 121 (31.8) | 2052 (37.1) | 939 (37.6) | 407 (41.4) | ||
| Stroke buckle, n (%) | 1738 (21.1) | 472 (21.1) | 95 (25.0) | 1074 (19.4) | 545 (21.8) | 230 (23.4) | ||
| Non–stroke belt or buckle, n (%) | 3919 (47.5) | 1012 (45.3) | 164 (43.2) | 2410 (43.5) | 1016 (40.6) | 347 (35.3) | ||
| Physiological risk factors | ||||||||
| Waist circumference, cm, mean (SD) | 94.9±14.8 | 94.6±15.8 | 96.0±16.4 | 0.22 | 95.9±16.0 | 96.6±16.1 | 98.8±17.0 | <0.001 |
| Diabetes mellitus, n (%) | 1077 (13.5) | 321 (14.9) | 78 (21.1) | <0.001 | 1172 (22.1) | 624 (26.1) | 274 (28.9) | <0.001 |
| Physical Component Summary score of SF‐12, mean (SD) | 50.6±7.8 | 47.8±10.4 | 45.5±12.1 | <0.001 | 47.0±9.9 | 43.1±11.2 | 39.3±11.9 | <0.001 |
| Systolic blood pressure, mm Hg, mean (SD) | 125.0±15.1 | 123.6±15.6 | 122.5±15.9 | <0.001 | 129.6±16.9 | 129.1±17.5 | 129.3±18.1 | 0.55 |
| Total cholesterol, mg/dL, mean (SD) | 193.9±37.1 | 195.5±37.6 | 196.5±36.5 | 0.10 | 196.1±40.1 | 197.5±42.1 | 199.1±43.3 | 0.08 |
| High‐density lipoprotein, mg/dL, mean (SD) | 52.0±16.3 | 53.5±16.4 | 54.1±17.6 | 0.0002 | 52.9±16.1 | 53.4±15.9 | 53.2±16.0 | 0.50 |
| Estimated glomerular filtration rate <60, n (%) | 482 (6.0) | 124 (5.8) | 19 (5.2) | 0.75 | 633 (12.0) | 299 (12.6) | 72 (7.7) | 0.002 |
| High‐sensitivity C‐reactive protein, mg/L, median (IQR) | 1.7 (0.8–4.0) | 2.1 (0.9–4.6) | 2.5 (1.2–6.2) | <0.001 | 2.5 (1.1–5.5) | 2.8 (1.2–6.5) | 3.5 (1.3–7.8) | <0.001 |
| Albumin:creatinine ratio >30 mg/g, n (%) | 775 (9.5) | 224 (10.4) | 32 (8.8) | 0.37 | 811 (15.4) | 406 (17.2) | 161 (17.5) | 0.06 |
| Medications | ||||||||
| Antihypertensive medication use, n (%) | 3391 (41.3) | 920 (41.7) | 164 (43.6) | 0.67 | 2863 (52.3) | 1388 (56.1) | 576 (59.3) | <0.001 |
| Statin use, n (%) | 2114 (25.7) | 517 (23.1) | 91 (24.1) | 0.04 | 1319 (23.9) | 639 (25.6) | 238 (24.3) | 0.24 |
| Behavioral risk factors | ||||||||
| Smoking | <0.001 | <0.001 | ||||||
| Current, n (%) | 851 (10.3) | 265 (11.9) | 88 (23.3) | 856 (15.5) | 455 (18.2) | 276 (28.1) | ||
| Never, n (%) | 4003 (48.6) | 1140 (51.3) | 163 (43.1) | 2545 (46.1) | 1149 (46.1) | 450 (45.9) | ||
| Past, n (%) | 3381 (41.1) | 818 (36.8) | 127 (33.6) | 2116 (38.4) | 890 (35.7) | 255 (26.0) | ||
| Alcohol use | 0.001 | 0.62 | ||||||
| Heavy, n (%) | 439 (5.4) | 105 (4.8) | 21 (5.6) | 181 (3.3) | 67 (2.8) | 31 (3.3) | ||
| Moderate, n (%) | 3622 (44.5) | 895 (40.7) | 141 (37.9) | 1371 (25.2) | 595 (24.4) | 233 (24.4) | ||
| None, n (%) | 4074 (50.1) | 1197 (54.5) | 210 (56.5) | 3895 (71.5) | 1774 (72.8) | 689 (72.3) | ||
| Physical inactivity, n (%) | 2125 (26.0) | 716 (32.5) | 153 (40.8) | <0.001 | 1896 (34.8) | 995 (40.3) | 458 (47.1) | <0.001 |
| Medication nonadherence, n (%) | 1950 (26.8) | 632 (31.7) | 141 (40.6) | <0.001 | 1342 (26.9) | 741 (33.1) | 367 (40.6) | <0.001 |
Elevated depressive symptoms were defined as a score ≥4 on the Center for Epidemiologic Studies–Depression scale, and elevated perceived stress was defined as a score ≥5 on the Perceived Stress Scale. P values from chi square, ANOVA tests. The stroke belt was defined as the states of Alabama, Arkansas, Louisiana, Mississippi, Tennessee, and the noncoastal regions within the states of North Carolina, South Carolina and Georgia. The stroke buckle was defined as coastal regions within the states of North Carolina, South Carolina, and Georgia. Diabetes mellitus was defined as fasting blood glucose ≥126 or random glucose >200 mL/dL, or oral hypoglycemic or insulin use. CVD was defined as baseline coronary heart disease, stroke, periphery artery disease, or aortic aneurism. CVD indicates cardiovascular disease; IQR, interquartile range; REGARDS, Reasons for Geographical and Racial Differences in Stroke; SF‐12, 12‐Item Short Form Health Survey.
Figure 1Kaplan–Meier survival curves for incident total cardiovascular disease (CVD) in participants with low and high income. Incident CVD includes nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death. REGARDS indicates Reasons for Geographical and Racial Differences in Stroke.
Association of Concurrent Depressive Symptoms and Perceived Stress With Incident Total CVD, Acute Coronary Heart Disease, Cardiovascular Death, and All‐Cause Mortality Shown Separately for REGARDS Participants With High and Low Income
| Variable | Income ≥$35 000 | Income <$35 000 | ||||
|---|---|---|---|---|---|---|
| No Depressive Symptoms and No/Low Stress (n=9265) | Elevated Depressive Symptoms or Stress (n=2504) | Elevated Depressive Symptoms and Stress (n=430) | No Depressive Symptoms and No/Low Stress (n=6385) | Elevated Depressive Symptoms or Stress (n=2937) | Elevated Depressive Symptoms and Stress (n=1137) | |
| Total CVD (incident nonfatal MI, nonfatal stroke, or cardiovascular death) | ||||||
| Number of events | 524 | 144 | 14 | 636 | 312 | 123 |
| Age‐adjusted IR/1000 person‐years (95% CI) | 6.8 (6.1–7.5) | 7.9 (6.6–9.4) | 5.2 (3.0–9.2) | 13.4 (12.3–14.7) | 16.2 (14.3–18.3) | 21.2 (17.6–25.7) |
| Age‐adjusted HR (95% CI) | Ref | 1.16 (0.96–1.41) | 0.77 (0.43–1.37) | Ref | 1.20 (1.05–1.38) | 1.53 (1.05–1.39) |
| Model 1 HR (95% CI) | Ref | 1.24 (1.03–1.51) | 0.90 (0.50–1.60) | Ref | 1.23 (1.07–1.42) | 1.58 (1.29–1.93) |
| Model 2 HR (95% CI) | Ref | 1.18 (0.97–1.42) | 0.85 (0.48–1.51) | Ref | 1.21 (1.05–1.39) | 1.54 (1.26–1.88) |
| Model 3 HR (95% CI) | Ref | 1.17 (0.97–1.42) | 0.78 (0.44–1.39) | Ref | 1.20 (1.04–1.38) | 1.48 (1.21–1.81) |
| Psychosocial risk and income interaction, | 0.11 | |||||
| Acute coronary heart disease | ||||||
| Number of events | 298 | 77 | 7 | 302 | 151 | 59 |
| Age‐adjusted IR/1000 person‐years (95% CI) | 4.0 (3.5–5.6) | 4.4 (3.5–5.6) | 2.6 (1.2–5.8) | 6.9 (6.1–7.8) | 8.3 (7.0–9.9) | 9.9 (7.6–13.0) |
| Age‐adjusted HR (95% CI) | Ref | 1.08 (0.84–1.40) | 0.66 (0.30–1.46) | Ref | 1.20 (0.99–1.47) | 1.45 (1.09–1.93) |
| Model 1 HR (95% CI) | Ref | 1.19 (0.91–1.54) | 0.80 (0.36–1.77) | Ref | 1.24 (1.02–1.52) | 1.50 (1.12–1.99) |
| Model 2 HR (95% CI) | Ref | 1.11 (0.86–1.43) | 0.74 (0.33–1.64) | Ref | 1.21 (1.00–1.48) | 1.44 (1.08–1.92) |
| Model 3 HR (95% CI) | Ref | 1.10 (0.85–1.43) | 0.68 (0.31–1.52) | Ref | 1.21 (0.99–1.47) | 1.37 (1.03–1.83) |
| Psychosocial risk and income interaction, | 0.33 | |||||
| Cardiovascular death | ||||||
| Number of events | 160 | 48 | 4 | 289 | 147 | 54 |
| Age‐adjusted IR/1000 person‐years (95% CI) | 1.7 (1.4–2.2) | 2.3 (1.7–3.2) | 1.2 (0.4–3.7) | 4.9 (4.2–5.6) | 6.2 (5.2–7.5) | 7.4 (5.5–7.4) |
| Age‐adjusted HR (95% CI) | Ref | 1.30 (0.94–1.81) | 0.78 (0.23–2.63) | Ref | 1.26 (1.03–1.54) | 1.59 (1.18–2.14) |
| Model 1 HR (95% CI) | Ref | 1.34 (0.96–1.87) | 0.87 (0.26–2.91) | Ref | 1.27 (1.04–1.56) | 1.59 (1.18–2.15) |
| Model 2 HR (95% CI) | Ref | 1.23 (0.88–1.72) | 0.77 (0.24–2.53) | Ref | 1.23 (1.002–1.50) | 1.61 (1.19–2.17) |
| Model 3 HR (95% CI) | Ref | 1.21 (0.86–1.69) | 0.71 (0.21–2.36) | Ref | 1.22 (0.99–1.49) | 1.54 (1.13–2.08) |
| Psychosocial risk and income interaction, | 0.54 | |||||
| All‐cause mortality | ||||||
| Number of events | 618 | 183 | 27 | 1043 | 506 | 191 |
| Age‐adjusted IR/1000 person‐years (95% CI) | 6.4 (5.8–7.2) | 8.2 (7.0–9.7) | 8.7 (5.8–13.1) | 19.2 (17.8–20.7) | 22.8 (20.6–25.3) | 28.4 (24.3–33.3) |
| Age‐adjusted HR (95% CI) | Ref | 1.31 (1.10–1.55) | 1.47 (0.98–2.21) | Ref | 1.21 (1.09–1.35) | 1.54 (1.32–1.80) |
| Model 1 HR (95% CI) | Ref | 1.34 (1.13–1.59) | 1.64 (1.09–2.48) | Ref | 1.24 (1.12–1.39) | 1.61 (1.37–1.88) |
| Model 2 HR (95% CI) | Ref | 1.26 (1.06–1.50) | 1.56 (1.03–2.26) | Ref | 1.22 (1.09–1.36) | 1.61 (1.37–1.89) |
| Model 3 HR (95% CI) | Ref | 1.25 (1.05–1.48) | 1.40 (0.92–2.12) | Ref | 1.21 (1.08–1.35) | 1.55 (1.31–1.82) |
| +SF‐12 PCS HR (95% CI) | Ref | 1.15 (0.96–1.37) | 1.27 (0.83–1.92) | Ref | 1.11 (0.99–1.24) | 1.33 (1.13–1.56) |
| Psychosocial risk and income interaction, | 0.53 | |||||
IRs and HRs for the psychosocial risk groups. Model 1 adjusts for age, sex, race, geographic region, and number of people in the household. Model 2 adjusts for model 1 covariates plus systolic blood pressure, self‐reported antihypertensive medication use, total cholesterol, high‐density lipoprotein cholesterol, statin use, log‐transformed albumin:creatinine ratio, log‐transformed high‐sensitivity C‐reactive protein, estimated glomerular filtration rate, waist circumference, and diabetes mellitus. Model 3 adjusts for model 2 covariates plus cigarette smoking, alcohol use, physical activity, and medication adherence. The final model for all‐cause mortality adjusts for model 3 covariates plus the PCS of the SF‐12. Missing data in covariates were imputed using chain equations in 10 data sets with sample bootstrapping. CVD indicates cardiovascular disease; HR, hazard ratio; IR, incidence rate; MI, myocardial infarction; PCS, Physical Component Summary score; Ref, reference value; REGARDS, Reasons for Geographical and Racial Differences in Stroke; SF‐12, 12‐Item Short Form Health Survey.
Incidence rate is significantly different compared with the group with no depression and no stress, P<0.05.
Incidence rate is significantly different compared with the group with no depression and no stress, P≤0.01.
Incidence rate is significantly different compared with the group with no depression and no stress, P≤0.001.
Significant at P<0.05.
Interaction term P value from the overall (not stratified) final model.
Figure 2Kaplan–Meier survival curves for all‐cause mortality in participants with low and high income. REGARDS indicates Reasons for Geographical and Racial Differences in Stroke.